700 more clinical trials has been running on cubeSolutions!
We are so pleased to tell you that as of January 2018, the number of Clinical Trials has been carried out by cubeSolutions exceeded 700+ studies.
We know that without the help of our esteemed clients, it would not have been able to get this achievement. <
In the sense of expressing our gratitude to our clients, we decided to distribute our new solutions; cubeTMF and cubeCONSENT for free.
This opportunity is offered to all Clients who will run their new clinical trials with cubeCDMS. however, this offer is only available in 2018. Please do not miss this opportunity!
cubeCONSENT debuted at (2017 MFDS / KSCD Annual conference).
The 2017 MFDS / KSCD Annual Conference, which is one of the largest clinical trial conferences in Korea was held at 5th Dec. 2017.
This time, CRScube inc. which is as known as a market-leader in Clinical Trial Solutions had brought a new solution called cubeCONSENT, an Electronic Consent Application. With a little effort, such as installing an application, users can now run the Paperless-informed consent in real time.
Conference attendees were given the opportunity to demonstrate their own cubeCONSENT and were amazed at its innovative simplicity and sophistication.
Hee-Nam Yoon, a Manager works for CRScube Inc. insisted that "We will provide cubeCONSENT to our clients for free who run new Clinical Trials in 2018 with cubeCDMS." As a leader in clinical trial solutions in Korea, we are giving back the love we have been receiving, and we are also promoting the market size of cubeCONSENT."
We are looking forward to having you on cubeCONSENT!!
Welcome to our booth at DIA Japan 2017 in Tokyo!
12th ~ 14th November, 2017
CRScube staff is attending to the 14th DIA Japan Annual Meeting 2017, one of the largest annual meeting in the filed of Clinical Trials.
The meeting will take place at Tokyo Big Sight from this November 12 to 14, in Ariake, Tokyo(Japan).
We invite you to visit our booth #14 and check our latest news in eClinical solutions, such as the world's most innovative EDC system equipped with intuitive UI and User-friendly features, and cubeTMF by which our clients could experience huge cost efficiency in running clinical trials without paper-rollings and time-consuming approval procedures. we will be happy to assist you!
If you need further support or want to place a meeting with our team, please contact: firstname.lastname@example.org
For more information about the event, you can visit its website www.diaglobal.org
Try the most convenient way of Data-Export!
The main purpose of implementing Clinical Trial is to gathering Safety & Effectiveness Data, and this Dataset means everything for Clinical Trial. Unfortunately, so far conducting parties have had to get through some inconvenience & inefficient way to export Dataset in appropriate format, because no EDC solutions have provided in-house exporting system but cubeCDMS.
cubeCDMS, developed by CRScube Inc. and now in service with highly recognizable status in North-East Asian Clinical Trial society is equipped with powerful Data-Exporting System, and it provides following features;
1. Real-time Dataset Export
2. Various downloadable format(SAS, Access, Excel, CSV)
3. Available to reflect both Domain or Labal to Excel format.
This brings huge convenient point to its users by allowing them to export Clinical Dataset without using any of external programs.
Furthermore, CRScube is now planning to upgrade this exporting system, dramatically cutting SAS file size by reducing unnecessary end spaces. plus, cubeCDMS will support to export in XPT format very soon. For more information, please contact email@example.com
The cubeCONSENT is coming.
We at CRScube would like to introduce our most recent solution soon slated to join our other offerings of eclinical solutions: cubeCONSENT.
As its name suggests, cubeCONSENT is a solution which will enable the informed consent process as well as its oversight to occur electronically.
Specifically, using cubeCONSENT via a smartphone application, patients will be able to review the informed consent and give their consent via an electronic signature; principal investigators will be able to countersign a patient-signed consent form and return its copy to the owner; and sponsors will be able to oversee and manage the entire process with the aid of helpful visual metrics and analytics.
All of this is to ensure a streamlined, well-managed, and transparent informed consent process as well as to contribute to the long term inspection-readiness and overall quality of your clinical trial.
So please stay tuned for more announcements regarding a release date, or contact us today for more information at firstname.lastname@example.org.